Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 140 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

18 trials in Phase 3/4

Results Transparency

2%

1 of 41 completed trials have results

Key Signals

34 recruiting1 with results

Enrollment Performance

Analytics

N/A
67(74.4%)
Phase 3
12(13.3%)
Phase 4
6(6.7%)
Phase 1
3(3.3%)
Phase 2
1(1.1%)
Early Phase 1
1(1.1%)
90Total
N/A(67)
Phase 3(12)
Phase 4(6)
Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (140)

Showing 20 of 140 trials
NCT07731542Not ApplicableRecruiting

Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial

Role: lead

NCT07728292Not ApplicableRecruiting

Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm

Role: lead

NCT07714941Not Yet Recruiting

EUS-Guided ATI and SWE in Individuals With Normal FibroScan

Role: lead

NCT06010576Not ApplicableRecruiting

Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy

Role: collaborator

NCT07707609Recruiting

Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

Role: lead

NCT07697352Phase 3Not Yet Recruiting

Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis

Role: lead

NCT07667166Recruiting

Composite Index for Outcome Burden in Acute Cholangitis

Role: lead

NCT07661043Not ApplicableNot Yet Recruiting

RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas

Role: lead

NCT07652632Not ApplicableRecruiting

Regenerative Endoscopy in Refractory Perianal Crohn's Disease

Role: lead

NCT07574970Recruiting

A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT

Role: lead

NCT07486518Not Yet Recruiting

A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

Role: lead

NCT06835374Not ApplicableRecruiting

Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study

Role: lead

NCT07620899Not ApplicableActive Not Recruiting

Biological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM)

Role: lead

NCT07431983Recruiting

Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

Role: lead

NCT07575295Recruiting

A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventive Coagulation for Intraprocedural Vessel Management During Peroral Endoscopic Myotomy

Role: lead

NCT07441824Phase 3Recruiting

Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis

Role: lead

NCT06955520Not ApplicableRecruiting

Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

Role: lead

NCT07399652Not ApplicableRecruiting

Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

Role: lead

NCT06953986Not ApplicableRecruiting

A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

Role: lead

NCT07371832Recruiting

A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Stapler for Colorectal Cancer Procedures

Role: lead